A Safety Study of SEA-BCMA in Patients With Multiple Myeloma
Research Question:
Is SEA-BCMA tan effective treatment for multiple myeloma (MM) and what side effects
(unwanted effects) may occur?
Basic Study Information
Purpose:
This trial will study SEA-BCMA, a monoclonal antibody, to find out whether it is an
effective treatment for multiple myeloma (MM) and what side effects (unwanted effects)
may occur. The study will have two parts. Part 1 of the study will find out how much
SEA-BCMA should be given for treatment and how often. Part 2 of the study will use
the dose found in Part 1 and look at how safe and effective the treatment is.
Location: University of Rochester Medical Center
Study Reference #: IMMY18128
Lead Researcher (Principal Investigator)
Lead Researcher:
Brea Lipe
Study Contact Information
Study Coordinator: Stephanie Short
Phone: (585) 276-7885
Email: Stephanie_Short@URMC.Rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search